Concepedia

Alkistis Mitropoulou

AM

Statistics

Publications

5

Citations

207

H-Index

5

Active since

2017

Affiliations

King's College London(Current)

Medical Research Council

Asthma UK

UCB Pharma (United Kingdom)

Alkistis Mitropoulou is an author at King's College London specializing in molecular biology, life sciences, and hypersensitivity.

ORCID

Publications per year

2017–2022

5

Publications

5

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab

Anna M. Davies, Elizabeth G. Allan, Anthony H. Keeble et al. · Journal of Biological Chemistry · 2017 · 86 citations · Full text

, , +14

Modulating co-translational protein folding by rational design and ribosome engineering

Minkoo Ahn, Tomasz Włodarski, Alkistis Mitropoulou et al. · Nature Communications · 2022 · 52 citations · Full text

, , +17

Structure of a patient-derived antibody in complex with allergen reveals simultaneous conventional and superantigen-like recognition

Alkistis Mitropoulou, H. J. M. Bowen, Tihomir Dodev et al. · Proceedings of the National Academy of Sciences · 2018 · 34 citations · Full text

, , +17

Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody

Jiun-Bo Chen, Faruk Ramadani, Marie O. Y. Pang et al. · Scientific Reports · 2018 · 25 citations · Full text

, , +17

Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization

Alkistis Mitropoulou, Tom Ceska, James T. Heads et al. · Acta Crystallographica Section F Structural Biology Communications · 2020 · 10 citations · Full text

, , +17

1–5 of 5